Navigation Links
Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Date:3/13/2008

SAN DIEGO, March 13 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that Senior Vice President and CFO William R. LaRue will present a corporate overview on Thursday, March 20, 2008 at 11:00am Eastern Time (8:00am Pacific Time) during the Cowen and Company 28th Annual Health Care Conference at the Marriott Copley Place in Boston, Massachusetts.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at http://www.cadencepharm.com. To access the presentation, click on the Investor Relations tab and then click on the link entitled "Events and Presentations" on the left side of the screen. A replay of the webcast will available approximately one hour after the live webcast concludes and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance(TM) (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Cadence(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals,
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
2. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
3. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
6. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIO Investor Forum
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
9. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. NPS Pharmaceuticals Reports 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytic...X:ONC; NASDAQ: ONCY ) announced today that in conn..., the underwriters have exercised in full their ov...7,500 units. Each unit is comprised of one common ...and was sold at a price of US$3.00 per unit. Each ...
(Date:12/2/2009)... JERUSALEM, Israel, December 2 ...aluating the preclinical (animal study) safety and... technology from Weill,Cornell Medical College and...eat inherited anemias such as Cooley,s Anemia. ,...nologies to expand, ex vivo,populations of stem/p...
(Date:12/2/2009)...CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zent..."), a global biopharmaceutical company focused on ...at the U.S. Food and Drug Administration (FDA) has...PI3K/Akt pathway inhibitor compound, perifosine (K... multiple myeloma. Keryx Biopharmaceuticals, Inc. ...
(Date:12/1/2009)... Dr. Kerry Solomon announced that he has joi...is redesigned website at www.DrKerrySolomon.com ,... Dr. Solomon is a proven LASIK, lens implant, and ...y recognized for his substantial contributions to ...er of Trusted LASIK Surgeons, which screens LASIK ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...ecuring venture investments, commercializing techn...ng innovative companies in Wisconsin will not read...into federal government dollars. , ,This is the p...reated by a collaboration between the Wisconsin lo...e national economic development agency GSP Consul...
... Building the Merge Healthcare of tomorrow, as c...will mean offshoring 150 jobs to a "more cost effe...8 percent of the financially troubled medical imag...tes, Canada, and Japan to regain the competitive e...ion initiative euphemistically labeled rightsizing...
...a natural biological response to the phrase securi...opaque film over the outside of the cornea wall, c... avoid this, I will do my best to stick to the ess... from comprehensive. So if your company is raising...ho is familiar with securities laws early so that ...
Other Biology Technology:New firm to help companies land federal dollars 2Merge offshoring jobs to "more cost-effective" workforce 2Merge offshoring jobs to "more cost-effective" workforce 3Securities compliance is part of raising capital 2Securities compliance is part of raising capital 3Securities compliance is part of raising capital 4
(Date:12/3/2009)...melt that occurred during the 2008-09 austral summ...ases for two main climate drivers, ENSO (El Nio - ... Annular Mode), according to Dr. Marco Tedesco, As...at The City College of New York. , Professor T... CUNY Graduate Center, added that Antarctic snowme...
(Date:12/2/2009)...cohol consumption before head and neck cancer diag...of death, according to published studies. Now, res...ose who continued these habits after cancer diagno...uit smoking; despite this, many still smoke. In ou...their cancer diagnosis, increasing their risk of d...
(Date:12/2/2009)... status did not prompt people participating in a l...screening program to pick up their cigarettes agai...er Epidemiology, Biomarkers & Prevention , a journ.... The December issue contains a special focus on t...d concern in the lung screening community that rea...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 1HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 2HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 3HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 4HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 5HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 6HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 7HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 8HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 9HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 10HMS Holdings Corp Announces Q2 2009 Results and Raises 2009 Guidance 53329 11Cutting Edge iPhone 28TM 29 iPod 28R 29 Touch Apps Improve Quality of Life for Those With Celiac Coeliac 26 Food Allergies 53324 1Cutting Edge iPhone 28TM 29 iPod 28R 29 Touch Apps Improve Quality of Life for Those With Celiac Coeliac 26 Food Allergies 53324 2Oscar Award Winner Dr A R Rahman inaugurates Apollo Childrens Hospital the First Standalone Quaternary Care Paediatric Hospital in the Apollo Hos 53321 1Oscar Award Winner Dr A R Rahman inaugurates Apollo Childrens Hospital the First Standalone Quaternary Care Paediatric Hospital in the Apollo Hos 53321 2
...t. 21 bioMETRX, Inc., (OTC,Bulletin Board: BMRX),...tivated products, today announced that Frank Santa...ed the Company,s Board of Directors,effective Octo...RX over 20 years of high level,security expertise.... Inc.,ASSA ABLOY Door Security Solutions, Diebold,...
...on-animal testing deadlines loom for manufacturers...o deodorant to shampoos, a meeting in Philadelphia...tors, and policy experts to address the impact of ...ries of deadlines for animal testing bans in the E...potential hazards from thousands of chemicals prev...
...(Oct. 20, 2008) -- Two teams of scientists from Ha...y (HST) at Brigham and Women,s Hospital have devel...system that is biocompatible, efficient at drug re...ctures can deliver clinically approved drugs in hi...he drug or generating toxic components, a problem ...
Other Biology News:bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors 2bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors 3Spotlight on cosmetic ingredients conference 2
...Kit containing Dermal Fibroblasts (rabbit) and med...FBS and 10% DMSO at passage 25 (approx), supplied ...lture is supplied as a long-term culture, and is g...tinuous growth from the date supplied, when used w...
...-Color RNA Spike-In Kit contains in vitro synthesi...anneal only to complementary control probes on Agi...ridization. The spike-ins serve as a positive micr...NOTE: This kit is a required component of the Agil...
...Array high-density functional protein microarray i...elucidation of proteinprotein interactions on a pr...S. cerevisiae open reading frames (ORFs) expressed...ate on a 1 inch x 3 inch nitrocellulose-coated sli...
...mechanical harvesting of cells • Blade design...th the growth surface • Designed for use in 2...l; Sterilized by gamma radiation and certified non...t number, created to easily match Cornings product...
Biology Products: